UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies

Osteoporosis international, 2019-01, Vol.30 (1), p.71-78

2019

Volltextzugriff (PDF)

Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years

Osteoporosis international, 2015-12, Vol.26 (12), p.2763-2771

2015

Volltextzugriff (PDF)

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study

Osteoporosis international, 2012, Vol.23 (1), p.351-363

2012

Volltextzugriff (PDF)

The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis

Calcified tissue international, 2002-08, Vol.71 (2), p.103-111

2002

Volltextzugriff (PDF)

Diagnosis and management of bone fragility in diabetes: an emerging challenge

Osteoporosis international, 2018-12, Vol.29 (12), p.2585-2596

2018

Volltextzugriff (PDF)

Vertebral Fractures: Clinical Importance and Management

The American journal of medicine, 2016-02, Vol.129 (2), p.221.e1-221.e10

2016

Volltextzugriff (PDF)

Population-based Canadian hip fracture rates with international comparisons

Osteoporosis international, 2010-08, Vol.21 (8), p.1317-1322

2010

Volltextzugriff (PDF)

Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab

Osteoporosis international, 2019-12, Vol.30 (12), p.2437-2448

2019

Volltextzugriff (PDF)

The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

Osteoporosis international, 2015-12, Vol.26 (12), p.2773-2783

2015

Volltextzugriff (PDF)

Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass

Osteoporosis international, 2010-05, Vol.21 (5), p.837-846

2010

Volltextzugriff (PDF)

Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis

The New England journal of medicine, 1997-08, Vol.337 (6), p.382-388

1997

Volltextzugriff (PDF)

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

Osteoporosis international, 2012-01, Vol.23 (1), p.317-326

2012

Volltextzugriff (PDF)

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

The journal of clinical endocrinology and metabolism, 2000-06, Vol.85 (6), p.2129-2134

2000

Volltextzugriff (PDF)

Monitoring strontium ranelate therapy in patients with osteoporosis

Osteoporosis international, 2009-07, Vol.20 (7), p.1101-1106

2009

Volltextzugriff (PDF)

Special report on the official positions of the International Society for Clinical Densitometry

Osteoporosis international, 2004-10, Vol.15 (10), p.779-784

2004

Volltextzugriff (PDF)

A scorecard for osteoporosis in Canada and seven Canadian provinces

Osteoporosis international, 2021-01, Vol.32 (1), p.123-132

2021

Volltextzugriff (PDF)

Bone management in hematologic stem cell transplant recipients

Osteoporosis international, 2018-12, Vol.29 (12), p.2597-2610

2018

Volltextzugriff (PDF)

Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies

Journal of bone and mineral research, 2010-10, Vol.25 (10), p.2256-2265

2010

Volltextzugriff (PDF)

Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial

Osteoporosis international, 2020-10, Vol.31 (10), p.1935-1942

2020

Volltextzugriff (PDF)

Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fracture

Osteoporosis international, 2018-11, Vol.29 (11), p.2545-2556

2018

Volltextzugriff (PDF)

Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis

Osteoporosis international, 2009-11, Vol.20 (11), p.1895-1902

2009

Volltextzugriff (PDF)

Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study

Osteoporosis international, 2015-01, Vol.26 (1), p.361-372

2015

Volltextzugriff (PDF)

Early changes in bone mineral density and trabecular bone score following allogeneic stem cell transplant

Bone marrow transplantation (Basingstoke), 2016-05, Vol.51 (5), p.738-740

2016

Volltextzugriff (PDF)

Assessment of bone status using speed of sound at multiple anatomical sites

Ultrasound in medicine & biology, 2001-10, Vol.27 (10), p.1337-1345

2001

Volltextzugriff (PDF)

1 – 25 von 324

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(300)
Mit Volltextzugriff
(275)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(237)
Humans
(236)
Life Sciences & Biomedicine
(230)
Female
(159)
Biological And Medical Sciences
(110)
Medical Sciences
(102)
Male
(98)
Middle Aged
(94)
Osteoporosis
(85)
Endocrinology & Metabolism
(78)
Aged
(76)
Psychiatry
(72)
Risk Factors
(68)
Adult
(65)
Schizophrenia
(62)
Psychology. Psychoanalysis. Psychiatry
(60)
Psychopathology. Psychiatry
(58)
Adult And Adolescent Clinical Studies
(55)
Schizophrenia - Genetics
(55)
Bone Density
(46)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies

Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study

The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis

Diagnosis and management of bone fragility in diabetes: an emerging challenge

Vertebral Fractures: Clinical Importance and Management

Population-based Canadian hip fracture rates with international comparisons

Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab

The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass

Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

Monitoring strontium ranelate therapy in patients with osteoporosis

Special report on the official positions of the International Society for Clinical Densitometry

A scorecard for osteoporosis in Canada and seven Canadian provinces

Bone management in hematologic stem cell transplant recipients

Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies

Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial

Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fracture

Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis

Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study

Early changes in bone mineral density and trabecular bone score following allogeneic stem cell transplant

Assessment of bone status using speed of sound at multiple anatomical sites

Suchergebnisse filtern